{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:30:07Z","timestamp":1794097807899,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T00:00:00Z","timestamp":1540080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY14H050006"],"award-info":[{"award-number":["LY14H050006"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY16H150007"],"award-info":[{"award-number":["LY16H150007"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["Q19H050010"],"award-info":[{"award-number":["Q19H050010"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["20170420167"],"award-info":[{"award-number":["20170420167"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.biopha.2018.10.106","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T05:38:53Z","timestamp":1541741933000},"page":"1327-1338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2"],"prefix":"10.1016","volume":"109","author":[{"given":"Ying","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiran","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haishan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaosheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2018.10.106_bib0005","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/ndt\/gfi159","article-title":"ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends","volume":"20","author":"Grassmann","year":"2005","journal-title":"Nephrol. Dial Transpl."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.106_bib0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ckj\/sfs164","article-title":"Renal replacement therapy in Europe-a summary of the 2010 ERA-EDTA Registry Annual Report","volume":"6","author":"Kramer","year":"2013","journal-title":"Clin. Kidney J."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.106_bib0015","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/089686080302300604","article-title":"Basic mechanisms and clinical implications of peritoneal fibrosis","volume":"23","author":"Margetts","year":"2003","journal-title":"Peritoneal Dialysis Int."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.106_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5966\/sctm.2015-0001","article-title":"The therapeutic potential of human umbilical mesenchymal stem cells from Wharton\u2019s jelly in the treatment of rat peritoneal dialysis-induced fibrosis","volume":"5","author":"Fan","year":"2016","journal-title":"Stem Cells Transl. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.106_bib0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ki.2013.81","article-title":"Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta1 signaling","volume":"84","author":"Ueno","year":"2013","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.106_bib0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/aor.12526","article-title":"Clinical validation of a peritoneal Dialysis prescription model in the Patient OnLine software","volume":"40","author":"Hodzic","year":"2016","journal-title":"Artif. Organs"},{"issue":"Suppl. 2","key":"10.1016\/j.biopha.2018.10.106_bib0035","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1177\/089686080902902S28","article-title":"Insulin resistance and glucose homeostasis in peritoneal dialysis. Peritoneal dialysis international","volume":"29","author":"Fortes","year":"2009","journal-title":"journal of the International Society for Peritoneal Dialysis"},{"issue":"3","key":"10.1016\/j.biopha.2018.10.106_bib0040","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.22721","article-title":"Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development","volume":"49","author":"Asahina","year":"2009","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biopha.2018.10.106_bib0045","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1093\/ndt\/gfr217","article-title":"Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors","volume":"26","author":"Colmont","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.106_bib0050","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/(SICI)1097-0029(19971115)39:4<372::AID-JEMT7>3.0.CO;2-J","article-title":"Expression and potential role of the extracellular matrix in hepatic ontogenesis: a review","volume":"39","author":"Amenta","year":"1997","journal-title":"Microsc Res Tech"},{"issue":"1","key":"10.1016\/j.biopha.2018.10.106_bib0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.1993.36","article-title":"Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha","volume":"43","author":"Topley","year":"1993","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.106_bib0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-4165(95)00153-0","article-title":"A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli. (1996)","volume":"1289","author":"Yoshioka","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.biopha.2018.10.106_bib0065","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1046\/j.1523-1755.1998.00899.x","article-title":"Expression of glucose transporters in human peritoneal mesothelial cells","volume":"53","author":"Schroppel","year":"1998","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.106_bib0070","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2337\/db10-1328","article-title":"SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function","volume":"60","author":"Jurczak","year":"2011","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.biopha.2018.10.106_bib0075","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/dom.12073","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks\u2019 treatment with empagliflozin once daily in patients with type 2 diabetes","volume":"15","author":"Heise","year":"2013","journal-title":"Diabetes Obes. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.106_bib0080","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/clpt.2008.250","article-title":"Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus","volume":"85","author":"Komoroski","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.106_bib0085","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation"},{"issue":"2016","key":"10.1016\/j.biopha.2018.10.106_bib0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lfs.2016.07.018","article-title":"Diabetes and exposure to peritoneal dialysis solutions alter tight junction proteins and glucose transporters of rat peritoneal mesothelial cells","volume":"161","author":"Debray-Garcia","year":"2016","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.106_bib0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ndt\/gft397","article-title":"Paracrine effects of transplanted mesothelial cells isolated from temperature-sensitive SV40 large T-antigen gene transgenic rats during peritoneal repair","volume":"29","author":"Kanda","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.106_bib0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/00365519850186580","article-title":"Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage","volume":"58","author":"Ivarsson","year":"1998","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.106_bib0105","first-page":"841","article-title":"Identification of endothelial and mesothelial cells in human omental tissue and in omentum-derived cultured cells by specific cell markers","volume":"63","author":"Potzsch","year":"1990","journal-title":"Lab. Investig."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.106_bib0110","first-page":"274","article-title":"Experience in primary culture of human peritoneal mesothelial cell","volume":"55","author":"Chen","year":"2012","journal-title":"Chin. J. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.106_bib0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/path.1711450204","article-title":"Mesothelial healing: morphological and kinetic investigations","volume":"145","author":"Whitaker","year":"1985","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.106_bib0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1681\/ASN.2010030246","article-title":"SGLT2 mediates glucose reabsorption in the early proximal tubule","volume":"22","author":"Vallon","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.106_bib0125","doi-asserted-by":"crossref","first-page":"F156","DOI":"10.1152\/ajprenal.00409.2012","article-title":"Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. American journal of physiology","volume":"304","author":"Vallon","year":"2013","journal-title":"Ren. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.106_bib0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1463-1326.2011.01518.x","article-title":"Long-term treatment with empagliflozin, a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats","volume":"14","author":"Thomas","year":"2011","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.106_bib0135","doi-asserted-by":"crossref","first-page":"e54442","DOI":"10.1371\/journal.pone.0054442","article-title":"Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?","volume":"8","author":"Panchapakesan","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2018.10.106_bib0140","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1681\/ASN.2004060436","article-title":"Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum","volume":"16","author":"Margetts","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.biopha.2018.10.106_bib0145","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ajpath.2014.04.014","article-title":"Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro","volume":"184","author":"Duan","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.biopha.2018.10.106_bib0150","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ndt\/gfv093","article-title":"Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agents","volume":"31","author":"Gnudi","year":"2016","journal-title":"Nephrol. Dialysis Transpl."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.106_bib0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jbbm.2005.08.001","article-title":"2-NBDG as a fluorescent indicator for direct glucose uptake measurement","volume":"64","author":"Zou","year":"2005","journal-title":"J. Biochem. Biophys. Methods"},{"issue":"9","key":"10.1016\/j.biopha.2018.10.106_bib0160","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1248\/bpb.b15-00005","article-title":"Use of flow cytometry for quantitative analysis of metabolism of viable but non-culturable (VBNC) Salmonella","volume":"38","author":"Morishige","year":"2015","journal-title":"Biol. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.106_bib0165","first-page":"725","article-title":"[A new fluorescence method for determination of sodium-glucose cotransporter 2 activity], Beijing da xue xue bao","volume":"44","author":"Zhang","year":"2012","journal-title":"Yi xue ban"},{"issue":"1","key":"10.1016\/j.biopha.2018.10.106_bib0170","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ab.2012.07.003","article-title":"Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2","volume":"429","author":"Kanwal","year":"2012","journal-title":"Anal. Biochem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218346341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218346341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:38:59Z","timestamp":1777876739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218346341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":34,"alternative-id":["S0753332218346341"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.10.106","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.10.106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}